Stay updated on NasoVAX Extension Safety and Immunogenicity Clinical Trial
Sign up to get notified when there's something new on the NasoVAX Extension Safety and Immunogenicity Clinical Trial page.

Latest updates to the NasoVAX Extension Safety and Immunogenicity Clinical Trial page
- Check4 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedThe page now shows revision v3.4.2, replacing the previous v3.4.1. This is a metadata update indicating a new page version.SummaryDifference0.1%

- Check40 days agoChange DetectedThe page shows a minor revision label update from v3.4.0 to v3.4.1 with no visible impact on study content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check47 days agoChange DetectedShow glossary toggle added; QC-related fields are relabeled to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and a new revision tag 'Revision: v3.4.0' appears. The previous labels and tag were 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.3%

- Check62 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4. This reflects a minor page version update.SummaryDifference0.1%

- Check83 days agoChange DetectedA new 'Locations' section appears with Maryland listed, and the page footer shows Revision: v3.3.3. The 'HHS Vulnerability Disclosure' link and the 'Maryland Locations' entry were removed.SummaryDifference0.3%

Stay in the know with updates to NasoVAX Extension Safety and Immunogenicity Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NasoVAX Extension Safety and Immunogenicity Clinical Trial page.